Hepatitis C virus infection associated with administration of intravenous immune globulin: A cohort study

JAMA

Volumn 276, Issue 19, 1996, Pages 1563-1567

  Bresee, Joseph S ^a,d   Mast, Eric E ^a,e   Coleman, Patrick J ^a   Baron, Miriam J ^b   Schonberger, Lawrence B ^a   Alter, Miriam J ^a   Jonas, Maureen M ^b   Yu, Mei Ying W ^c   Renzi, Paula M ^c   Schneider, Lynda C ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d Mailstop G17   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS TRANSMISSION;

EID: 10544234190     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.19.1563     Document Type: Article

References (20)

1. Lane RS. Non-A, non-B hepatitis from intravenous immunoglobulin. Lancet. 1983:2:974-975.
2. Lever AML, Brown D, Webster ADB, Thomas HC. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet 1984;2:1062-1064.
3. Ochs HD, Fischer SH, Virant FS, Lee ML, Mankarious S, Wedgwood RJ. Non-A, non-B hepatitis and intravenous immunoglobulin. Lancet. 1985;1: 404-405.
4. Weiland O, Mattsson L, Glauman H. Non-A, non-B hepatitis after intravenous immunoglobulin. Lancet. 1986;1:976-977.
5. Björkander J, Cunningham-Rundles C, Lundin P, et al. Intravenous immunoglobulin: prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988;84:107-111.
6. Williams PE, Yap PL, Gillon J, et al. Non-A, non-B hepatitis transmission by intravenous immunoglobulin. Lancet. 1988;2:501.
7. Yap PL, McOmish F, Webster ADB, et al. Hepatitis C transmission by intravenous immunoglobulin. J Hepatol. 1994;20:455-460.
8. Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep. 1994;43:505-509.
9. Yu MYW, Mason BL, Tankersley DL. Detection and characterization of hepatitis C virus RNA in immune globulins. Tranfusion. 1994;34:596-602.
10. Finlayson JS, Tankersley DL. Anti-HCV screening and plasma fractionation: the case against. Lancet. 1990;335:1274-1275.
11. Yei S, Yu MW, Tankersley DL. Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma. Transfusion. 1992;32:824-828.
12. Biswas RM, Nedjar S, Wilson LT, et al. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion. 1994:34:100-104.
13. Yu MW, Mason BL, Guo ZP, et al. Hepatitis C transmission associated with intravenous immunoglobulin. Lancet. 1995;345:1173-1174.
14. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med. 1992; 327:1899-1905.
15. Lai ME, Virgilis SD, Argiolu F, et al. Evaluation of hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. J Pediatr Gastroenter Nutr. 1993; 16:458-464.
16. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih JW. Serologic markers of post-transfusion hepatitis C viral infection. J Clin Microbriol. 1992;30:552-556.
17. Marcellin P, Martinot-Peignoux M, Elias A, et al. HCV viremia in HIV seronegative and seropositive patients with indeterminate HCV recombinant immunoblot assay. J Infect Dis. 1994;170:433-435.
18. Lok ASF, Chien D, Choo Q, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology. 1993;18:497-502.
19. Davis GL. Hepatitis B and C: influence of immunosuppression. Recent Results Cancer Res. 1993; 132:213-220.
20. Martin P, DiBisceglie AM, Kassianides C. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989;97:1559-1561.